Opens in a new tab

Profitable Knitwear Business with Western Customers

Profitable Knitwear Business with Western Customers
Country
BangladeshBangladesh
Listing ID
L#20220401
Target Price
$3,750,000
Revenue
$2,868,576
EBITDA
TBA

Description

Company has an apparel manufacturing unit in Bangladesh with 8 line knitwear and sewing section.

The organization has 5 customers from Italy, Europe and South Korea ordering around 150,000 to 250,000 pieces per year.

The business has contracts with clients to produce apparel under clients' brand names, the raw materials are locally sourced.

The production capacity is around 10,000 cloth pieces per day buy utilizing only 4 lines out of 8 at present.

Basic Details

Listing ID
L#20220401
Country
Bangladesh
City
Gazipur
Industry
Manufacturing
Deal Status
Available
Reason for Selling
New Venture
Target Price
$3,750,000
Revenue
$2,868,576
EBITDA
TBA
Revenue Multiple
1.31x
EBITDA Multiple
TBD
FF&E
Includes physical assets worth EUR 1.1 million

M&A Middle Market Advisory Deal Tombstones 2024

AdvisorDeals
MergersCorp M&A International21
Keith Advisory17
GCG9
JP Morgan41
Jefferies23
Lazard26
Goldman Sachs30

Businesses for Sale

Similar Opportunities

KazakhstanKazakhstanManufacturingL#20261174

Central Asian Chlor-Alkali & Chemicals Manufacturing Platform

The proposed project entails the development of a state-of-the-art, vertically integrated chlor-alkali and downstream specialty chemical manufacturing cluster in Kazakhstan. Capitalizing on abundant domestic salt reserves, competitive operating fundamentals, and strategic Eurasian logistics corridors, the project is structured to substitute…

Target Price
$1,000,000,000
Revenue
$620,000,000
EBITDA
$186,000,000
United StatesUnited StatesManufacturingL#20261103

American Leading Life Sciences Research Services Platform

A leading independent multi-omics service providers in the Americas. The Company provides a comprehensive portfolio of next-generation sequencing (NGS), proteomics, metabolomics, epigenomics, and bioinformatics solutions to research institutions, hospitals, biotechnology companies, and pharmaceutical clients across North and South America. Following…

Target Price
$44,000,000
Revenue
$57,000,000
EBITDA
$3,700,000